Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,837 | -15,272 | -10,831 | -5,240 | -23,792 |
| Depreciation Amortization | 184 | 135 | 87 | 43 | 169 |
| Accounts receivable | 50 | 24 | 16 | 9 | -111 |
| Other Working Capital | -404 | -1,553 | -1,415 | -2,427 | 4,421 |
| Other Operating Activity | 2,354 | 2,718 | 762 | 263 | -1,626 |
| Operating Cash Flow | $-18,654 | $-13,949 | $-11,381 | $-7,353 | $-20,938 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -40 | -36 | -33 | -58 |
| Investing Cash Flow | $-48 | $-40 | $-36 | $-33 | $-58 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -41 | -31 | -21 | -10 | -42 |
| Financing Cash Flow | $-41 | $-31 | $-21 | $-10 | $-42 |
| Exchange Rate Effect | 565 | -89 | 632 | 2 | 2,246 |
| Beginning Cash Position | 44,055 | 44,323 | 44,234 | 43,960 | 64,535 |
| End Cash Position | 25,878 | 30,215 | 33,428 | 36,567 | 45,744 |
| Net Cash Flow | $-18,178 | $-14,108 | $-10,806 | $-7,394 | $-18,791 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,654 | -13,949 | -11,381 | -7,353 | -20,938 |
| Capital Expenditure | -48 | -40 | -36 | -33 | -58 |
| Free Cash Flow | -18,701 | -13,989 | -11,417 | -7,385 | -20,995 |